NovaCross CTO Microcatheter
Catheter, Percutaneous. 510(k) K193322, from Nitiloop , Ltd. (Pardes Hanna, IL). Product code DQY, class 2.
As of Nov 20, 2026, K193322 is an FDA 510(k) held by Nitiloop , Ltd., substantially equivalent on Apr 2, 2020 after 122 days, with no recalls tied to it in FDA's recall database.
- Review time: 122 days
- Recalls: 0
The NovaCross CTO Microcatheter is intended to facilitate the intraluminal placement of conventional and steerable guidewires beyond the stenotic lesions, including chronic total occlusions (CTOs), and prior to PTCA or stent intervention.
- Crossboss Catheter Model M-2000, Stingray Orienting Balloon Catheter Model M-1000, Stingray Guidewire Model M-3004 and MK102725 · Bridge Medical, Inc. · May 10, 2011
- ASAHI PTCA Guide Wires, ASAHI Corsair Microcatheter, ASAHI Corsair Pro MicrocatheterK171933 · Asahi Intecc Co., Ltd. · Feb 12, 2018
- CrossFAST Integrated Microcatheter Advanced Delivery SystemK262817 · Vantis Vascular, Inc. · Sep 18, 2026
- NHanceITK260559 · IMDS Operation B.V. · Aug 14, 2026
- APRO 35 Swift CatheterK262392 · Alembic, LLC · Aug 12, 2026
- CPS Locator 3D Plus Delivery CatheterK261766 · CenterPoint Systems, LLC · Jul 29, 2026
- SSPC NXT Delivery CatheterK262240 · CenterPoint Systems, LLC · Jul 29, 2026
- Amplatzer TorqVue LP Delivery System; Amplatzer TorqVue LP CatheterK261825 · Abbott · Jul 2, 2026
- Amplatzer TorqVue Exchange SystemK261631 · Abbott Medical · Jun 17, 2026
- Perfect-O Ostial Positioning CatheterK260289 · Balosmark, Inc. · Jun 5, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 2, 2019
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files